EW Historical PE Ratio image   This EW PE ratio history page last updated 8/1/2022
EW PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2022
7/28/2022
107.290.632.2847.1
Q1 2022
4/26/2022
116.270.602.2950.8
Q4 2021
1/26/2022
108.630.512.2348.7
Q3 2021
10/27/2021
116.070.542.2252.3
Q2 2021
7/29/2021
111.620.642.1951.0
Q1 2021
4/20/2021
89.630.541.8947.4
Q4 2020
1/27/2021
84.840.501.8545.9
Q3 2020
10/21/2020
83.610.511.8445.4
Q2 2020
7/23/2020
77.320.341.8043.0
Q1 2020
4/23/2020
73.680.501.9238.4
Q4 2019
1/30/2020
77.990.491.8641.9
Q3 2019
10/23/2019
75.060.471.7642.6
Q2 2019
7/23/2019
65.150.461.6539.5
Q1 2019
4/23/2019
60.330.441.6037.7
Q4 2018
1/31/2019
56.810.391.5736.2
Q3 2018
10/23/2018
49.430.361.4933.2
Q2 2018
7/26/2018
51.690.411.4136.7
Q1 2018
4/24/2018
44.890.411.3633.0
Q4 2017
2/1/2018
42.330.311.2633.6
Q3 2017
10/24/2017
38.080.281.2031.7
Q2 2017
7/26/2017
38.540.361.1533.5
Q1 2017
4/25/2017
32.970.311.0431.7
Q4 2016
2/1/2017
32.670.250.9733.7
Q3 2016
10/25/2016
37.890.230.9340.7
Q2 2016
7/26/2016
36.120.250.8841.0
Q1 2016
4/26/2016
36.280.240.8244.2
Q4 2015
2/2/2016
25.640.210.7733.3
Q3 2015
10/26/2015
24.490.180.7433.1
Q2 2015
7/28/2015
25.970.190.6937.6
Q1 2015
4/23/2015
23.650.190.6536.4
Q4 2014
2/3/2015
21.170.180.5935.9
Q3 2014
10/23/2014
17.530.130.5631.3
Q2 2014
7/29/2014
14.070.150.5426.1
Q1 2014
4/24/2014
13.380.130.5325.2
Q4 2013
2/3/2014
10.700.150.5220.6
Q3 2013
10/28/2013
12.210.110.5024.4
Q2 2013
7/25/2013
11.780.140.4924.0
Q1 2013
4/23/2013
13.800.120.4630.0
Q4 2012
2/4/2013
15.510.130.4336.1
Q3 2012
10/19/2012
14.360.10NANA
Q2 2012
7/24/2012
16.440.11NANA
Q1 2012
4/24/2012
12.220.09NANA
EW Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2022
7/28/2022
107.290.632.5242.6
Q1 2022
4/26/2022
116.270.602.4048.4
Q4 2021
1/26/2022
108.630.512.0453.2
Q3 2021
10/27/2021
116.070.542.1653.7
Q2 2021
7/29/2021
111.620.642.5643.6
Q1 2021
4/20/2021
89.630.542.1641.5
Q4 2020
1/27/2021
84.840.502.0042.4
Q3 2020
10/21/2020
83.610.512.0441.0
Q2 2020
7/23/2020
77.320.341.3656.9
Q1 2020
4/23/2020
73.680.502.0036.8
Q4 2019
1/30/2020
77.990.491.9639.8
Q3 2019
10/23/2019
75.060.471.8839.9
Q2 2019
7/23/2019
65.150.461.8435.4
Q1 2019
4/23/2019
60.330.441.7634.3
Q4 2018
1/31/2019
56.810.391.5636.4
Q3 2018
10/23/2018
49.430.361.4434.3
Q2 2018
7/26/2018
51.690.411.6431.5
Q1 2018
4/24/2018
44.890.411.6427.4
Q4 2017
2/1/2018
42.330.311.2434.1
Q3 2017
10/24/2017
38.080.281.1234.0
Q2 2017
7/26/2017
38.540.361.4426.8
Q1 2017
4/25/2017
32.970.311.2426.6
Q4 2016
2/1/2017
32.670.251.0032.7
Q3 2016
10/25/2016
37.890.230.9241.2
Q2 2016
7/26/2016
36.120.251.0036.1
Q1 2016
4/26/2016
36.280.240.9637.8
Q4 2015
2/2/2016
25.640.210.8430.5
Q3 2015
10/26/2015
24.490.180.7234.0
Q2 2015
7/28/2015
25.970.190.7634.2
Q1 2015
4/23/2015
23.650.190.7631.1
Q4 2014
2/3/2015
21.170.180.7229.4
Q3 2014
10/23/2014
17.530.130.5233.7
Q2 2014
7/29/2014
14.070.150.6023.5
Q1 2014
4/24/2014
13.380.130.5225.7
Q4 2013
2/3/2014
10.700.150.6017.8
Q3 2013
10/28/2013
12.210.110.4427.8
Q2 2013
7/25/2013
11.780.140.5621.0
Q1 2013
4/23/2013
13.800.120.4828.8
Q4 2012
2/4/2013
15.510.130.5229.8
Q3 2012
10/19/2012
14.360.100.4035.9
Q2 2012
7/24/2012
16.440.110.4437.4
Q1 2012
4/24/2012
12.220.090.3633.9
Quotes delayed 20 minutes

Email EnvelopeFree EW Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Edwards Lifesciences (EW) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

EWTX PE Ratio History
EXAS PE Ratio History
EXEL PE Ratio History
EYE PE Ratio History
EYEG PE Ratio History
EYEN PE Ratio History
EYES PE Ratio History
EYPT PE Ratio History
FATE PE Ratio History
FBIO PE Ratio History
On this page we presented the EW PE Ratio History information for Edwards Lifesciences' stock. The average EW PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 35.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EW PE ratio history based on this TTM earnings result method is 37.3.

Let's now compare this EW PE ratio history result, against the recent PE: when this page was posted on 7/29/2022, the most recent closing price for EW had been 100.54, and the most recent quarterly earnings result, annualized, was 2.52. Meanwhile, the most recent TTM earnings summed to 2.28. From these numbers, we calculate the recent EW PE on 7/29/2022 based on annualized quarterly EPS was 39.9. Based on EW's history, that recent PE is elevated relative to the historical average, with the recent PE 13.0% higher than the historical average PE across our data set for Edwards Lifesciences. Looking at the recent EW PE on 7/29/2022 based on TTM EPS, we calculate the ratio at 44.1. Based on EW's history, that recent PE is elevated relative to the historical average, with the recent PE 18.2% higher than the historical average PE across our Edwards Lifesciences data set with TTM EPS used in the calculation at each period.

Another interesting EW PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for EW, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for EW, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.51, 0.54, 0.60, and 0.63. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.54 and 0.60 — which gives us the median of 0.57. Basically the way to think about this 0.57 number is this: for the trailing four earnings reports, 0.57 marks the "middle ground" number where EW has reported a value higher than 0.57 half the time, and has reported a value lower than 0.57 half the time. Annualizing that median value then gets us to 2.28/share, which we use as the denominator in our next PE calculation. With 100.54 as the numerator (as of 7/29/2022), the calculation is then 100.54 / 2.28 = 44.1 as the EW PE ratio as of 7/29/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on EW or any other given stock, valuation analysis for EW can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Edwards Lifesciences PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for EW. Thanks for visiting, and the next time you need to research EW PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: WETF Dividend History, MBAC Historical Stock Prices, RACA shares outstanding history.

 

EW PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.